We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's What Key Metrics Tell Us About Aon (AON) Q2 Earnings
Read MoreHide Full Article
Aon (AON - Free Report) reported $3.76 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 18.4%. EPS of $2.93 for the same period compares to $2.76 a year ago.
The reported revenue represents a surprise of +1.01% over the Zacks Consensus Estimate of $3.72 billion. With the consensus EPS estimate being $3.09, the EPS surprise was -5.18%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Aon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
Consolidated - Organic Revenue Growth: 6% versus the eight-analyst average estimate of 6.6%.
Wealth Solutions - Organic Revenue Growth: 9% versus 3.7% estimated by six analysts on average.
Health Solutions - Organic Revenue Growth: 6% versus 6% estimated by six analysts on average.
Commercial Risk Solutions - Organic Revenue Growth: 6% compared to the 4% average estimate based on six analysts.
Reinsurance Solutions - Organic Revenue Growth: 7% compared to the 6.2% average estimate based on six analysts.
Revenue- Commercial Risk Solutions: $2.02 billion versus $1.96 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +13.6% change.
Revenue- Reinsurance Solutions: $635 million versus $643.85 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +4.6% change.
Revenue- Wealth Solutions: $463 million versus the six-analyst average estimate of $428.27 million. The reported number represents a year-over-year change of +31.5%.
Revenue- Intersegment elimination: -$15 million versus -$3.63 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +400% change.
Revenue- Health Solutions: $662 million compared to the $629.20 million average estimate based on six analysts. The reported number represents a change of +48.1% year over year.
Shares of Aon have returned +2.1% over the past month versus the Zacks S&P 500 composite's -1.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's What Key Metrics Tell Us About Aon (AON) Q2 Earnings
Aon (AON - Free Report) reported $3.76 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 18.4%. EPS of $2.93 for the same period compares to $2.76 a year ago.
The reported revenue represents a surprise of +1.01% over the Zacks Consensus Estimate of $3.72 billion. With the consensus EPS estimate being $3.09, the EPS surprise was -5.18%.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Aon performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Consolidated - Organic Revenue Growth: 6% versus the eight-analyst average estimate of 6.6%.
- Wealth Solutions - Organic Revenue Growth: 9% versus 3.7% estimated by six analysts on average.
- Health Solutions - Organic Revenue Growth: 6% versus 6% estimated by six analysts on average.
- Commercial Risk Solutions - Organic Revenue Growth: 6% compared to the 4% average estimate based on six analysts.
- Reinsurance Solutions - Organic Revenue Growth: 7% compared to the 6.2% average estimate based on six analysts.
- Revenue- Commercial Risk Solutions: $2.02 billion versus $1.96 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +13.6% change.
- Revenue- Reinsurance Solutions: $635 million versus $643.85 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +4.6% change.
- Revenue- Wealth Solutions: $463 million versus the six-analyst average estimate of $428.27 million. The reported number represents a year-over-year change of +31.5%.
- Revenue- Intersegment elimination: -$15 million versus -$3.63 million estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +400% change.
- Revenue- Health Solutions: $662 million compared to the $629.20 million average estimate based on six analysts. The reported number represents a change of +48.1% year over year.
View all Key Company Metrics for Aon here>>>Shares of Aon have returned +2.1% over the past month versus the Zacks S&P 500 composite's -1.2% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.